Inmed Pharmaceuticals Inc Stock Number Of Shares Shorted

MWG0 Stock   4.17  0.23  5.84%   
INMED PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to INMED PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of INMED Stock. The fundamental analysis module provides a way to measure INMED PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INMED PHARMACEUTICALS stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

INMED PHARMACEUTICALS INC Company Number Of Shares Shorted Analysis

INMED PHARMACEUTICALS's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Shares Shorted

 = 

Shorted by Public

+

by Institutions

More About Number Of Shares Shorted | All Equity Analysis
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Based on the recorded statements, INMED PHARMACEUTICALS INC has 0.0 of outstending shares currently sold short by investors. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Number Of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

About INMED PHARMACEUTICALS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze INMED PHARMACEUTICALS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INMED PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INMED PHARMACEUTICALS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in INMED Stock

INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.